Kefir-derived Lacticaseibacillus paracasei as a promising candidate against planktonic and biofilm cells of foodborne Escherichia coli and Klebsiella pneumoniae
Letters in Applied Microbiology · 2026
DOI: 10.1093/lambio/ovag069 ↗Kurz gefasst
Fachartikel in der Zeitschrift Letters in Applied Microbiology, 2026. Verfasst von Victor Alves Carneiro und 6 weiteren Autor:innen. Beteiligte Einrichtung: Center for Bioprospecting and Applied Molecular Experimentation (NUBEM/LaBAM), University Center INTA - UNINTA, Sobral, Ceará 60.192-010, Brazil. Hauptthemen laut MEDLINE: Biofilms, Klebsiella pneumoniae, Probiotics, Escherichia coli. Die Arbeit nennt 38 Literaturangaben. Gefördert von: Cearense Foundation for the Support of Scientific and Technological Development.
Abstract (Originalsprache)
This study aimed to identify kefir-derived microorganisms, evaluate their probiotic potential to select the most promising strain, and assess the selected strain’s antibacterial and antibiofilm activities against foodborne isolates, Escherichia coli, and Klebsiella pneumoniae. Kefir grains were cultivated in selective media, and isolates were identified using MALDI-TOF mass spectrometry. Their acid and NaCl tolerance, auto- and co-aggregation, and antimicrobial activity were assessed to identify the most effective probiotic strain. Subsequently, the selected strain was subjected to spot overlay tests, broth microdilution assays, and biofilm inhibition experiments against E. coli and K. pneumoniae isolates. Enterococcus durans, Leuconostoc pseudomesenteroides, Lacticaseibacillus paracasei, and Kluyveromyces marxianus were identified. Among these, L. paracasei (Lpk-01) demonstrated the best probiotic characteristics, with 50% survival at pH 5, tolerance to 2% NaCl, and high co-aggregation with K. pneumoniae (40%). It inhibited pathogens (inhibition zones > 14 mm), and its cell-free supernatant (Lpk-cf) reduced biofilm biomass by ∼50%, with effects minimized upon neutralization, suggesting the involvement of organic acids. These findings affirm the antimicrobial potential of L. paracasei, highlighting its application as a natural alternative against bacterial pathogens.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Bioprospecting and Applied Molecular Experimentation (NUBEM/LaBAM), University Center INTA - UNINTA, Sobral, Ceará 60.192-010, Brazil.
- Laboratory of Biofilms and Antimicrobial Agents (LaBAM), Faculty of Medicine, Federal University of Ceará - UFC, Sobral, Ceará 62.048-280, Brazil.
- Northeast Network of Biotechnology Program (RENORBIO), State University of Ceará, Campus Itaperi, Fortaleza, Ceará 60.714-903, Brazil.
ORCID-Profile: Victor Alves Carneiro
Förderung
- Cearense Foundation for the Support of Scientific and Technological Development
Zitieren
APA
Carneiro, V. A., Lourenço, M. L. M. C., Magalhães, E. V. F., Coelho, P. A. T., Silva, B. F., Cavalcante, R. M. B., & Costa, R. A. (2026). Kefir-derived Lacticaseibacillus paracasei as a promising candidate against planktonic and biofilm cells of foodborne Escherichia coli and Klebsiella pneumoniae. Letters in Applied Microbiology. https://doi.org/10.1093/lambio/ovag069
Vancouver
Carneiro VA, Lourenço MLMC, Magalhães EVF, Coelho PAT, Silva BF, Cavalcante RMB, et al. Kefir-derived Lacticaseibacillus paracasei as a promising candidate against planktonic and biofilm cells of foodborne Escherichia coli and Klebsiella pneumoniae. Letters in Applied Microbiology. 2026. doi:10.1093/lambio/ovag069
BibTeX
@article{Carneiro2026,
author = {Carneiro, Victor Alves and Lourenço, Maria Leilah Monte Coelho and Magalhães, Edrine Vasconcelos Farias and Coelho, Paulo Adenes Teixeira and Silva, Benise Ferreira and Cavalcante, Rafaela Mesquita Bastos and Costa, Renata Albuquerque},
title = {Kefir-derived Lacticaseibacillus paracasei as a promising candidate against planktonic and biofilm cells of foodborne Escherichia coli and Klebsiella pneumoniae},
journal = {Letters in Applied Microbiology},
year = {2026},
doi = {10.1093/lambio/ovag069}
}
EUVIMED